Open Access
Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial
Chunjuan Wang, Hong-Qiu Gu, Qiang Dong, Anding Xu, Ning Wang, Yi Yang, Feng Wang, Yongjun Wang
DOI: 10.1136/svn-2023-002938 Published 30 December 2024
Chunjuan Wang
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Hong-Qiu Gu
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Qiang Dong
3
Department of Neurology, Huashan Hospital, Fudan University, Shanghai, Shanghai, China
Anding Xu
4
Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou, China
Ning Wang
5
Department of Neurology, The First Affiliated Hospital, Institute of Neuroscience, Fujian Medical University, Fuzhou, China
Yi Yang
6
Department of Neurology, The First Hospital of Jilin University, Changchun, China
Feng Wang
7
State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, China
Yongjun Wang
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
8
Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Beijing, China
9
Chinese Institute for Brain Research, Beijing, China
10
Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China

Submit a Response to This Article
No eLetters have been published for this article.
Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial
Chunjuan Wang, Hong-Qiu Gu, Qiang Dong, Anding Xu, Ning Wang, Yi Yang, Feng Wang, Yongjun Wang
Stroke and Vascular Neurology Dec 2024, 9 (6) 730-737; DOI: 10.1136/svn-2023-002938

Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial
Chunjuan Wang, Hong-Qiu Gu, Qiang Dong, Anding Xu, Ning Wang, Yi Yang, Feng Wang, Yongjun Wang
Stroke and Vascular Neurology Dec 2024, 9 (6) 730-737; DOI: 10.1136/svn-2023-002938
Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial
Chunjuan Wang, Hong-Qiu Gu, Qiang Dong, Anding Xu, Ning Wang, Yi Yang, Feng Wang, Yongjun Wang
Stroke and Vascular Neurology Dec 2024, 9 (6) 730-737; DOI: 10.1136/svn-2023-002938